Announcement of the partial amendment of the Company's
2021 Annual Report
Date of events
2022/08/11
To which item it meets
paragraph 50
Statement
1.Date of receipt of letter from TPEx to request
supplement or correction:2022/08/09
2.Deadline imposed for supplement or correction:2022/08/11
3.Content of supplement or correction:
According to the instructions of the OTC Buying Center:
(1)Some contents on pages 13,14,19,20,21,22,29 and 37of the
company's 2021 annual report in Chinese version were corrected.
(2)Some contents on pages 14,15,19,20,21,33,34 and 47 of the
company's 2021 annual report in English version were corrected.
4.Countermeasures:
To upload the Company's revised 2021 Annual Reports onto the MOPS.
5.Any other matters that need to be specified:None
Attachments
Original Link
Original Document
Permalink
Disclaimer
Raku Co. Ltd. published this content on 11 August 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 11 August 2022 07:30:06 UTC.
Raku Co Ltd, formerly Kino Biotech Co., Ltd., is a Singapore-based company. The Company is an integrated bio-nutraceutical and cosmeceutical company. The Company is focused on product conceptualization, development, commercialization, brand marketing, sale and distribution of healthcare and beauty products. The Company provides healthcare and beauty products and services through brands, including Kinohimitsu, Activa and Xpertise. It has over two logistic and distribution centers in Malaysia and China. The Company provides products to China, Singapore, Malaysia, Vietnam, Thailand and Indonesia.
RAKU CO., LTD 
